Literature DB >> 6967838

Immunoregulatory T-cell function in acute and chronic liver disease.

S Kakumu, K Yata, T Kashio.   

Abstract

The suppressor function of T cells separated from the peripheral blood lymphocytes of patients with acute or chronic liver disease was evaluated by using, as an indicator system, pokeweed mitogen-induced immunoglobulin synthesis in vitro. Suppressor activity of T cells was enhanced during the recovery phase in 13 or 17 patients who have recovered from acute viral hepatitis. When such T cells were irradiated before coculture, the suppressor function was selectively eliminated, but the helper T-cell function remained unchanged. In serial studies, normalization of the excess suppressor function of T cells was observed when the liver function of an acute viral hepatitis patient returned to the normal range. Except for chronic active liver disease, in which the suppressor activity of T cells was substantially reduced in 50% of the patients studied. the studies indicated normal T-cell functions, both suppressor and helper, in other liver diseases such as chronic persistent hepatitis, inactive cirrhosis, and fatty liver disease. These data sugest that the host immunoregulatory mechanism might be important in recovering from acute viral hepatitis and in perpetuating hepatocyte injury in chronic active liver disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967838

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.

Authors:  H Hirofuji; S Kakumu; A Fuji; Y Ohtani; K Murase; H Tahara
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; G Mieli-Vergani; G Kenna; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

4.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

Review 5.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

Review 6.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitis.

Authors:  V Barnaba; E Tamburrini; V Laghi; R Cauda; M Levrero; G Ruocco; L Ortona; F Balsano
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

8.  Increased peripheral blood Ia positive T cells and their effect on autologous mixed lymphocyte reaction in chronic active liver disease.

Authors:  K Fukui; S Kakumu; H Murakami; J Kuriki; K Yoshioka; N Sakamoto
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

10.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.